Citius Oncology (CTOR) Shares Outstanding (Entity) (2021 - 2026)
Citius Oncology's Shares Outstanding (Entity) came in at 105.76 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 47.8% from 71.55 million a year earlier and up 13.7% from the prior quarter.
Powered by 
Analysis
Citius Oncology (CTOR) Shares Outstanding (Entity) (2021 - 2026) Analysis & Trends
For FY2025 (ended Sep 30, 2025), Citius Oncology's Shares Outstanding (Entity) was 83.51 million, up 16.7% from FY2024.
- Shares Outstanding (Entity) carries a four-year compound annual growth rate of 163.8% (FY2021 to FY2025).
- Going back by fiscal year, Shares Outstanding (Entity) was 71.55 million in FY2024, 67.5 million in FY2023, 3.21 million in FY2022 (+85.9%) and 1.73 million in FY2021.
- The fiscal Q3 2026 figure represents the highest quarterly Shares Outstanding (Entity) in data going back to fiscal Q4 2021.
- Year-over-year, Shares Outstanding (Entity) has increased for four consecutive quarters, with growth averaging 28.2% over the last four quarters.
- Business Quant data shows CTOR's Shares Outstanding (Entity) at 92.98 million (Q2 2026), 84.8 million (Q1 2026) and 83.51 million (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 940.75 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.41 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 1.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.47 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 540.90 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.24 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 5.70 Bn |
| 10 | Citius Oncology | 60.42 Mn | 30.00 Mn | 1.00 Mn | 107.89 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 107.89 Mn |
| Mar 31, 2026 | 92.98 Mn |
| Dec 31, 2025 | 84.80 Mn |
| Sep 30, 2025 | 73.27 Mn |
| Jun 30, 2025 | 71.55 Mn |
| Mar 31, 2025 | 71.55 Mn |
| Dec 31, 2024 | 71.55 Mn |
| Sep 30, 2024 | 68.05 Mn |
| Jun 30, 2024 | 6.65 Mn |
| Mar 31, 2024 | 4.74 Mn |
| Dec 31, 2023 | 67.50 Mn |
| Sep 30, 2023 | 8.94 Mn |
| Jun 30, 2023 | 9.02 Mn |
| Mar 31, 2023 | 9.02 Mn |
| Dec 31, 2022 | 3.21 Mn |
| Sep 30, 2022 | 1.73 Mn |
| Mar 31, 2022 | 1.73 Mn |
| Dec 31, 2021 | 1.73 Mn |
API Access
Citius Oncology Shares Outstanding (Entity) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=CTOR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-entity", "ticker": "CTOR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=CTOR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();